Table 3.

Characteristics Associated with Knowledge of Adult Pneumococcal Vaccine Recommendations (n=588)

Variable	Answered 0–5 correctly Row % (n) n=424 (72%)	Answered 6–8 correctly Row % (n) n=164 (28%)	Bivariate RR* (95% CI)	Bivariate p value	Multivariable RR* (95% CI)
Specialty
FP	78 (217)	22 (61)	0.66 (0.50–0.87)		0.69 (0.53–0.91)
GIM	67 (207)	33 (103)	Ref.	0.002	Ref.
Gender
Male	75 (240)	25 (79)	Ref.
Female	68 (184)	32 (85)	1.28 (0.98–1.65)	0.07
Age group
Less than 50	64 (130)	36 (74)	Ref.		Ref.
50–59	76 (158)	24 (51)	0.67 (0.50–0.91)		0.71 (0.53–0.96)
60 or more	77 (133)	23 (39)	0.63 (0.45–0.87)	0.005	0.65 (0.47–0.90)
Setting
Private practice	72 (301)	28 (117)	Ref.
Hospital or clinic	70 (93)	30 (39)	1.06 (0.78–1.43)
HMO	79 (30)	21 (8)	0.75 (0.40–1.42)	0.57
Census Location
Urban	69 (193)	31 (85)	1.21 (0.93–1.59)
Suburban	75 (211)	25 (71)	Ref.
Rural	71 (20)	29 (8)	1.13 (0.61–2.11)	0.36
Region
Midwest	74 (121)	26 (42)	0.81 (0.58–1.13)
Northeast	72 (76)	28 (30)	0.89 (0.61–1.29)
South	68 (124)	32 (58)	Ref.
West	75 (103)	25 (34)	0.78 (0.54–1.12)	0.49
Current ACIP recommendations for pneumococcal vaccinations for adults are Very Clear
Yes	65 (188)	35 (100)	1.57 (1.20–2.06)		1.50 (1.15–1.96)
No	78 (226)	22 (64)	Ref.	0.0007	Ref.
Automated, computer-based way to identify adults <65 who need PCV13 based on their medical conditions
Yes	77 (138)	23 (42)	0.76 (0.56–1.03)
No	69 (277)	31 (122)	Ref.	0.07
Automated, computer-based way to identify adults <65 who need PPSV23 based on their medical conditions
Yes	74 (165)	26 (57)	0.86 (0.65–1.13)
No	70 (250)	30 (107)	Ref.	0.26

^*RR=risk ratio